Clinical Trials Directory

Trials / Unknown

UnknownNCT06115655

A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles

Status
Unknown
Phase
Study type
Observational
Enrollment
161 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to detect the methylation characteristics of cfDNA in the bile and plasma of patients with bile duct stricture. The main question it aims to answer is: Can the developed model, using peripheral blood and bile cell-free DNA sequencing, work well in screening and classifying unknown biliary stricture? Participants will collect approximately 10ml of peripheral blood and 5ml of bile from the patient.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcfDNA methylation detectionExtract cfDNA from bile and plasma, and perform methylation detection.

Timeline

Start date
2023-10-01
Primary completion
2024-10-01
Completion
2024-10-30
First posted
2023-11-03
Last updated
2023-11-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06115655. Inclusion in this directory is not an endorsement.